SHAWN ALLEN
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology ST GEORGE, UT NPI 1083147441
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology UT ABBVIE INC. All categories
General Payments — all program years on this page
$5,779.51
- Category: General Payments
- Program years: PY2022–2024
- Record count: 181
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,768.00 across 80 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,768.00 | 80 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $410.52 | 21 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $166.69 | 6 |
| Abbott Laboratories | $154.47 | 2 |
| ARGENX US, INC. | $123.90 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $101.63 | 3 |
| Lundbeck LLC | $87.55 | 5 |
| PFIZER INC. | $80.62 | 4 |
| Biogen, Inc. | $74.27 | 4 |
| UCB, Inc. | $63.30 | 3 |
| Genentech USA, Inc. | $59.39 | 3 |
| Averitas Pharma Inc. | $49.81 | 2 |
| ACADIA Pharmaceuticals Inc | $47.18 | 3 |
| EMD Serono, Inc. | $45.01 | 2 |
| ANI Pharmaceuticals, Inc. | $38.43 | 2 |
| Neurocrine BioSciences, Inc. | $30.79 | 2 |
| Lilly USA, LLC | $27.43 | 2 |
| Grifols USA, LLC | $25.46 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $22.59 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.67 | 1 |
| EISAI INC. | $20.61 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.82 | 1 |
| SPR Therapeutics, Inc | $19.39 | 1 |
| Kedrion Biopharma, Inc. | $18.09 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $18.05 | 1 |
| Amneal Pharmaceuticals LLC | $16.21 | 1 |
| BANNER LIFE SCIENCES, LLC | $15.35 | 1 |
| INSIGHTEC,INC | $10.77 | 1 |
By program year
Records — PY2024 (80)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.